National Nanotechnology Laboratory (NNL)-Institute of Nanoscience (NANO), CNR, Lecce, Italy.
Lab Chip. 2013 Jun 21;13(12):2328-36. doi: 10.1039/c3lc00055a. Epub 2013 May 3.
We have developed an integrated microfluidic platform for producing 2-[(18)F]-fluoro-2-deoxy-D-glucose ((18)F-FDG) in continuous flow from a single bolus of radioactive isotope solution, with constant product yields achieved throughout the operation that were comparable to those reported for commercially available vessel-based synthesisers (40-80%). The system would allow researchers to obtain radiopharmaceuticals in a dose-on-demand setting within a few minutes. The flexible architecture of the platform, based on a modular design, can potentially be applied to the synthesis of other radiotracers that require a two-step synthetic approach, and may be adaptable to more complex synthetic routes by implementing additional modules. It can therefore be employed for standard synthesis protocols as well as for research and development of new radiopharmaceuticals.
我们开发了一种集成微流控平台,可从放射性同位素溶液的单个射流中连续流动生产 2-[(18)F]-氟-2-脱氧-D-葡萄糖((18)F-FDG),整个操作过程中的产物收率保持恒定,与市售基于容器的合成器相当(40-80%)。该系统可让研究人员在几分钟内按需获得放射性药物。该平台基于模块化设计的灵活架构,可潜在地应用于需要两步合成方法的其他放射性示踪剂的合成,并且通过实施附加模块,可能适用于更复杂的合成路线。因此,它可用于标准合成方案,以及用于新放射性药物的研发。